title: Whole-genome analysis personalizes breast cancer treatment.
abstract: In the SAFIR01 trial, whole-genome analysis was performed in samples from 248 patients with metastatic breast cancer, and genomic alterations targetable by cancer drugs were found in 172 of the tumors.
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D005260:Female; D055106:Genome-Wide Association Study; D023281:Genomics; D006801:Humans; D057285:Precision Medicine